These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12730808)
1. Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Vargas V; Rimola A; Casanovas T; Castells L; Navasa M; Baliellas C; Bilbao I; Visa J; Jaurrieta E; Margarit C Transpl Int; 2003 Apr; 16(4):270-5. PubMed ID: 12730808 [TBL] [Abstract][Full Text] [Related]
2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM; Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [TBL] [Abstract][Full Text] [Related]
3. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395 [TBL] [Abstract][Full Text] [Related]
4. Exclusions and deaths on the liver transplant waiting list. Cadahía V; González-Diéguez ML; Alonso P; García-Bernardo C; Miyar de León A; Barneo L; Vázquez L; González-Pinto IM; Rodríguez M Transplant Proc; 2010 Mar; 42(2):622-4. PubMed ID: 20304208 [TBL] [Abstract][Full Text] [Related]
5. A new liver transplant priority for patients with hepatocellular carcinoma. Ravaioli M; Grazi GL; Vetrone G; Kimura T; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Tuci F; Cucchetti A; La Barba G; Vivarelli M; Lauro A; Ramacciato G; Pinna AD Hepatogastroenterology; 2008; 55(86-87):1742-5. PubMed ID: 19102382 [TBL] [Abstract][Full Text] [Related]
6. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Maddala YK; Stadheim L; Andrews JC; Burgart LJ; Rosen CB; Kremers WK; Gores G Liver Transpl; 2004 Mar; 10(3):449-55. PubMed ID: 15004776 [TBL] [Abstract][Full Text] [Related]
7. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139 [TBL] [Abstract][Full Text] [Related]
9. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Lo CM; Fan ST; Liu CL; Chan SC; Wong J Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774 [TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for hepatocellular carcinoma in Singapore. Wai CT; Lee YM; Wang SC; Da Costa M; Isaac J; Wee A; Lim SG Singapore Med J; 2006 Jul; 47(7):584-7. PubMed ID: 16810428 [TBL] [Abstract][Full Text] [Related]
11. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O; Perrella A; Arenga G Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085 [TBL] [Abstract][Full Text] [Related]
12. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Shah SA; Cleary SP; Tan JC; Wei AC; Gallinger S; Grant DR; Greig PD Ann Surg Oncol; 2007 Sep; 14(9):2608-14. PubMed ID: 17522942 [TBL] [Abstract][Full Text] [Related]
13. Referral patterns and waiting times for liver transplantation in Singapore. Lim SG; Wai CT; Da Costa M; Sutedja DS; Lee YM; Lee KH; Tan CK; Aw MM; Quak SH; Prabhakaran K; Tan KC; Isaac J Singapore Med J; 2006 Jul; 47(7):599-603. PubMed ID: 16810432 [TBL] [Abstract][Full Text] [Related]
14. Survival benefit after liver transplantation: a single European center experience. Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783 [TBL] [Abstract][Full Text] [Related]
15. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival. Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258 [TBL] [Abstract][Full Text] [Related]
16. Liver transplantation in New Zealand: the first four years. Gane E; McCall J; Streat S; Gunn K; Yeong ML; Fitt S; Keenan D; Munn S N Z Med J; 2002 Aug; 115(1159):U120. PubMed ID: 12362165 [TBL] [Abstract][Full Text] [Related]
17. Deaths on the liver transplant waiting list: an analysis of competing risks. Kim WR; Therneau TM; Benson JT; Kremers WK; Rosen CB; Gores GJ; Dickson ER Hepatology; 2006 Feb; 43(2):345-51. PubMed ID: 16440361 [TBL] [Abstract][Full Text] [Related]
18. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Ravaioli M; Masetti M; Ridolfi L; Capelli M; Grazi GL; Venturoli N; Di Benedetto F; Bianchi FB; Cavrini G; Faenza S; Begliomini B; Pinna AD; Gerunda GE; Ballardini G Transplantation; 2007 Apr; 83(7):919-24. PubMed ID: 17460563 [TBL] [Abstract][Full Text] [Related]
19. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma. Pierie JP; Muzikansky A; Tanabe KK; Ott MJ Ann Surg Oncol; 2005 Jul; 12(7):552-60. PubMed ID: 15889217 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]